IP Library Granted Patent US 9,808,539
Granted Patent B2
US 9,808,539 · App. 14/202,178 · Granted Nov 7, 2017

Hypoosmotic solutions for lymph node detection

Inventors: Andrew P. Shawcross (Cambridge, GB); John Gonzalez-Carvajal (Haslemere, GB); Marc Brown (Watford, GB); Rob Turner (Portsmouth, GB)
Assignee: ENDOMAGNETICS LTD.
A61K49/1806A61K41/0052A61K49/1863A61N2/002
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,808,539
App. No.
14/202,178
Granted
Nov 7, 2017
Kind
B2
Abstract

Provided are compositions for rapid detection of lymph nodes. The compositions include magnetic particles, such as iron oxide, and a solute present in an amount that results in a hypoosomotic solution. Methods for detecting lymph nodes also are provided.

Claims (26)

1. A hypoosmotic suspension for medical injection comprising:

about 13 mg/mL to about 200 mg/mL of superparamagnetic particles; and

an osmolyte selected from either about 0.01% w/v to about 0.6% w/v of an inorganic salt or about 0.5% w/v to about 1.5% w/v of a glycol

wherein the hypoosmotic suspension has an osmolality of about 80 mOsm/kg to about 160 mOsm/kg.

2. The hypoosmotic suspension of claim 1 , wherein the superparamagnetic particles are iron oxide.

3. The hypoosmotic suspension of claim 1 , comprising between about 13 mg/ml and 53 mg/ml of superparamagnetic particles.

4. The hypoosmotic suspension of claim 1 , further comprising an excipient.

5. The hypoosmotic suspension of claim 1 wherein the superparamagnetic particles are coated.

6. The hypoosmotic suspension of claim 5 , wherein the coating comprises dextran.

7. The hypoosmotic suspension of claim 1 , wherein the inorganic salt is sodium chloride.

8. The hypoosmotic suspension of claim 1 , wherein the suspension is used for the detection of sentinel nodes and comprises about 0.05%-0.3% w/v of the inorganic salt.

9. The hypoosmotic suspension of claim 1 , wherein the glycol is propylene glycol.

10. The hypoosmotic suspension of claim 1 , wherein the suspension is used for magnetic hyperthermia treatment and comprises about 20 mg/ml-200 mg/ml of the superparamagnetic particles.

11. A method of locating a lymph node in a patient, the method comprising the steps of:

providing the hypoosmotic suspension of claim 1 ;

injecting the hypoosmotic suspension into the patient;

waiting until the superparamagnetic particles become entrapped in a lymph node; and

detecting the location of the lymph node by detecting the location of the superparamagnetic particles.

12. A method of location a lymph node in a patient, the method comprising the step of:

providing the hypoosmotic suspension of claim 1 ;

providing a hypoosmotic suspension comprising superparamagnetic particles, injecting the hypoosmotic suspension into the patient; and detecting a lymph node within 5 minutes of injection by detection the location of the superparamagnetic particles, the detecting sufficient to immediately begin a medical procedure on the lymph node based on the detecting.

13. A method of treating a patient using magnetic hyperthermia, the method comprising the steps of:

providing the hypoosmotic suspension of claim 1 ;

injecting the hypoosmotic suspension into the patient; and

exposing the patient to an alternating magnetic field.

14. The hypoosmotic suspension of claim 1 , wherein the inorganic salt is selected from the group consisting of sodium chloride, potassium chloride, magnesium chloride, ammonium chloride, sodium sulfate, sodium phosphate, potassium phosphate, calcium chloride, magnesium sulfate, potassium acetate, and sodium acetate.

Assignments (6)
SECURITY INTEREST Recorded Jul 1, 2024
From: MEDPHARM LIMITED
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 067881/0666 →
RELEASE OF SECURITY INTEREST Recorded Jan 17, 2024
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: MEDPHARM LIMITED
Reel/Frame 066155/0458 →
PATENT SECURITY AGREEMENT Recorded Jan 4, 2021
From: MEDPHARM LIMITED
To: WELLS FARGO BANK, NATIONAL ASSOCIATION
Reel/Frame 054892/0506 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2014
From: SHAWCROSS, ANDREW P.; GONZALEZ-CARVAJAL, JOHN
To: ENDOMAGNETICS LTD.
Reel/Frame 033793/0441 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2014
From: BROWN, MARC; TURNER, ROB
To: MEDPHARM LTD.
Reel/Frame 033793/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 22, 2014
From: MEDPHARM LTD.
To: ENDOMAGNETICS LTD.
Reel/Frame 033793/0453 →
Continuity (2)
Provisional Application 61775780 · Mar 11, 2013
Related Publication 20140314679A1 · Oct 23, 2014